For more than 25 years Vernalis has collaborated with partners to tackle challenging therapeutic targets, supporting drug discovery programmes from gene to candidate through platform services such as hit-ID and assay, protein science, biophysics/structural biology, chemistry & computational chemistry, cell biology, and DMPK.